PYP Scintigraphy is Insufficient as a Non-Invasive Diagnostic Tool: Time for PET!
We Recommend
Disclosures
Within the last 24 months, I have had financial relationship(s) with the ineligible company or companies listed below:
- Consultant Fee/Honoraria/Speaker's Bureau - AstraZenca
- Grant Support/Research Contract - Pfizer; Attralus; Phillips